Expanding psychologists’ scope of practice would undermine continuity of care: CFPCThe College of Family Physicians of Canada is urging the Ontario government to reconsider its plan to expand the scopes of practice for psychologists and other health professionals. Drug News—December 2025A review of new launches, new indications, new dosage forms and Health Canada advisories. NEW PRODUCT: Rystiggo for myasthenia gravis Get the info you need on this new product, part of our drug news roundup for December. NEW PRODUCT: Tzield to delay onset of stage 3 type 1 diabetes Get the info you need on this new product, part of our drug news roundup for December. December drug news roundup: Three new drug indications pharmacists and physicians should know about Get the info you need on these new indications, part of our drug news roundup for December. NEW PRODUCT: Anzupgo for chronic hand eczema Get the info you need on this new product, part of our drug news roundup for December. Can’t take hormone therapy for menopause? What are other options? Beyond lifestyle changes, some nonhormonal prescription medicines have been shown to ease menopausal symptoms. GLP-1 RAs are increasingly being used to lose weight after childbirth New study provides contemporary data on the frequency of glucagon-like peptide 1 receptor agonist use for postpartum weight reduction. Weight loss interventions can cause new skin issues to crop up for your patients Paradoxically, bariatric surgery is sometimes responsible for the development of new pathologies. Do you sometimes slip into ‘essentially placebo treatment’ as a way to manage patient expectations? A new study explores how 'essentially placebo' treatments raise questions about the transparency and trust that underpin the doctor-patient relationship. First Previous 9 10 11 12 13 Next Last
